qPharmetra provides pharmacometric analysis, clinical pharmacology consulting and custom software tools to help drug companies develop better medicines.
Newsflash
-
Introducing three new colleagues!
Introducing three new colleagues!
-
New Publications
New Publications
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N-dimethyltryptamine benzoate) in healthy participants
https://www.linkedin.com/feed/update/urn:li:activity:7200888698358431744A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders
https://www.linkedin.com/feed/update/urn:li:activity:7184520052254085120A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations
https://www.linkedin.com/feed/update/urn:li:activity:7183377271368392704 -
Pharmacometrics Network Benelux meeting in Leuven
Pharmacometrics Network Benelux meeting in Leuven
-
Career Opportunities at qP
Career Opportunities at qP
Looking for a new career opportunity? qPharmetra is always interested in talented people who share our vision of better decisions, better medicines and will thrive with our creative, collaborative and consistent way of working. More information @qP/Careers
- Senior Quantitative Clin Pharm Consultant
- Quantitative Clin Pharm Consultant
- Senior Pharmacometrics Consultant
- Pharmacometrics Consultant
- Associate Pharmacometrics Consultant
